Rv1630 - p.Asp264Glu
Drug resistance types
0 Sensitive
9 RR-TB
2 HR-TB
2 MDR-TB
3 Pre-XDR-TB
0 XDR-TB
4 Other
lineage Counts
| lineage | Count |
|---|---|
| La1.8.1 | 1 |
| lineage4.9 | 7 |
| lineage4.4.1.2 | 1 |
| lineage2.2.1 | 2 |
| lineage4.2.1 | 1 |
| lineage4.3.2.1 | 1 |
| lineage3 | 2 |
| lineage4.5 | 1 |
| lineage4.8 | 1 |
| lineage3.1.2.1 | 1 |
| lineage2.2;lineage4 | 1 |
| lineage2.2.1;lineage4.5 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 20 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| ERR5311077 | Other | La1.8.1 | None |
| ERR4769493 | Other | lineage4.9 | None |
| ERR3797062 | RR-TB | lineage4.9 | None |
| ERR126597 | HR-TB | lineage4.4.1.2 | None |
| SRR16156697 | RR-TB | lineage2.2.1 | None |
| SRR14782539 | MDR-TB | lineage4.2.1 | None |
| ERR502470 | RR-TB | lineage4.9 | None |
| ERR3283006 | RR-TB | lineage4.9 | None |
| ERR4816322 | Other | lineage4.9 | None |
| SRR11349147 | RR-TB | lineage4.3.2.1 | None |
| ERR4815079 | RR-TB | lineage3 | None |
| SRR11972425 | Pre-XDR-TB | lineage2.2.1 | None |
| ERR4816852 | Other | lineage4.9 | None |
| ERR4816548 | HR-TB | lineage4.5 | None |
| SRR9971122 | MDR-TB | lineage4.8 | None |
| SRR6045002 | RR-TB | lineage4.9 | None |
| ERR4816717 | RR-TB | lineage3.1.2.1 | None |
| SRR16156832 | RR-TB | lineage2.2;lineage4 | None |
| ERR4811035 | Pre-XDR-TB | lineage2.2.1;lineage4.5 | None |
| SRR5341267 | Pre-XDR-TB | lineage3 | None |
